Surgery Performed on 25-Year-Old Valley Man after Dirt Bike Accident
Neurosurgeons at Barrow Neurological Institute have implanted the world’s first scaffolding device into the spinal cord of a patient.
Continue reading
Author Archives: D3Bio
Coming out of the Shadows: EMA approves first treatment for EPP
Perseverance and adaptability are requisite qualities in drug development.
Arizona Events to Support America’s Vets this November
This November AZBio is partnering with great organizations that support our Veterans and also providing information on how Veterans can be trained to become valuable team members in our life science businesses.Continue reading
Calimmune (Tucson, AZ) Approved to Treat Second Group in HIV Stem Cell Gene Modification Study
June 25, 2014
San Diego, CA – Calimmune today announced encouraging safety data from its innovative gene-based stem cell therapy, Cal-1-being developed to help cure individuals infected with HIV. The company can now begin treating the second group of patients in the trial, which is being funded in part by a grant from the California Institute for Regenerative Medicine (CIRM).Continue reading
Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Rare Form of Epilepsy, Lennox-Gastaut Syndrome
Insys Therapeutics, Inc. (INSY), a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery systems, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to its pharmaceutical cannabidiol (CBD) for the treatment of Lennox-Gastaut Syndrome, a rare pediatric-onset epilepsy.
Continue reading
Battelle/BIO Release State Bioscience Jobs, Investments and Innovation 2014 Report
Battelle/BIO State Bioscience Jobs, Investments and Innovation 2014:
A Robust Bioscience Industry with Strong Prospects for GrowthContinue reading
NAU and TGen forge five-year cooperative agreement and celebrate new patent and other joint research success
Better patient care provided through new NAU-TGen tests for deadly MRSA, Valley Fever and other infectious diseases that threaten public healthContinue reading
HTG receives US patent for HTG EdgeSeq chemistry
HTG Receives US Patent for HTG EdgeSeq Chemistry Coupling Quantitative Nuclease Protection With Next-Generation-SequencingContinue reading
Transplant For Life reaches important milestone in helping heal more lives in Arizona
Transplant For Life (TFL) becomes Arizona’s only FDA registered and accredited independent transplant tissue bank. Located in Phoenix, TFL is dedicated to enhancing lives in the community by facilitating the gift of transplant tissue donation.Continue reading
Senestech signs exclusive licensing agreement with Neogen
AZBio Member Senestech has entered into an exclusive licensing agreement with Neogen to manufacture and market a rodent control product that uses fertility control to manage rat populations.Continue reading